| Q51025899 | Aortic arterial stiffness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris. |
| Q26783501 | Atherosclerosis in psoriatic disease: latest evidence and clinical implications |
| Q50333986 | Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis. |
| Q92462247 | Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis |
| Q59370664 | Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies. |
| Q47218445 | Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis |
| Q38970218 | Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries |
| Q47224549 | Double trouble: psoriasis and cardiometabolic disorders. |
| Q26771723 | Dyslipidemia in Dermatological Disorders |
| Q36506489 | Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom |
| Q38749538 | Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis |
| Q37648544 | Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. |
| Q34981499 | Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database |
| Q37629138 | Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice |
| Q92338380 | Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis |
| Q92537620 | Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review |
| Q33848992 | Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women |
| Q37696815 | Increased risk of stroke in contact dermatitis patients: A nationwide population-based retrospective cohort study |
| Q34855603 | LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNFα treatment |
| Q64250717 | Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome |
| Q53096105 | Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. |
| Q64946734 | Linking CD1-Restricted T Cells With Autoimmunity and Dyslipidemia: Lipid Levels Matter. |
| Q48239956 | Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). |
| Q38194199 | Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies |
| Q92367533 | Obesity and dyslipidemia in patients with psoriasis: A case-control study |
| Q90248096 | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities |
| Q36946167 | Presence of selected metabolic syndrome components in patients with psoriasis vulgaris |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q35045850 | Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications |
| Q35470124 | Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures |
| Q35966928 | Psoriasis and cardiovascular risk assessment in primary care |
| Q30235889 | Psoriasis and comorbid diseases: Epidemiology |
| Q34418506 | Psoriasis and comorbidities: links and risks |
| Q35263254 | Psoriasis and dyslipidemia |
| Q38151781 | Psoriasis and smoking: a systematic review and meta-analysis |
| Q37540440 | Psoriasis comorbidities: complications and benefits of immunobiological treatment |
| Q41108229 | Psoriasis-associated vascular disease: the role of HDL. |
| Q87736667 | Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents |
| Q50353072 | Risk of sudden sensorineural hearing loss in patients with psoriasis: a retrospective cohort study. |
| Q53019536 | Subclinical systemic and vascular inflammation detected by (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with mild psoriasis. |
| Q49404216 | The prevalence of cardiovascular diseases risk factors associated with psoriasis in Saudi Arabia |
| Q30250110 | Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms |
| Q37690746 | Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference. |